CYP1B1型
化学
酶
A549电池
肺癌
癌症研究
细胞
细胞生长
转移
细胞色素P450
生物利用度
生物化学
代谢稳定性
癌细胞
CYP3A4型
基因亚型
药理学
微粒体
癌症
细胞培养
化疗
作用机理
同工酶
细胞迁移
细胞凋亡
程序性细胞死亡
博莱霉素
酶抑制剂
肿瘤进展
酶分析
作者
Ting Wang,Haoyu Zhang,Bohou Song,Yujiang Fu,Dihan Tan,Ningyi Qin,Dongmei Zhao,Xiaoqiu Liu,Yang Liu,Maosheng Cheng
标识
DOI:10.1021/acs.jmedchem.6c01308
摘要
Metastasis represents a major cause of chemotherapy failure in non-small cell lung cancer (NSCLC). To explore the role of CYP1B1 enzymatic activity in NSCLC metastasis, we established A549 and H460 cells overexpressing wild-type CYP1B1, an activity-enhanced variant (L432V), and an activity-reduced variant (N203S). CYP1B1 did not affect cell proliferation but promoted migration and invasion, with the extent of these effects being associated with CYP1B1 enzymatic activity. We then designed and synthesized a series of CYP1B1 inhibitors. Compound G26 exhibited high selectivity over other CYP isoforms (IC50 = 5.33 nM), showed favorable microsomal metabolic stability with species differences, significantly inhibited migration and invasion in A549 and H460 cells, exhibited moderate oral bioavailability in SD rats (F = 20.7%), and showed a favorable safety profile in mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI